Seguir
Chandrasekar Gopalakrishnan, MD, MPH
Chandrasekar Gopalakrishnan, MD, MPH
Principal Epidemiologist at OM1, Inc.
Email confirmado em om1.com
Título
Citado por
Citado por
Ano
Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn
KF Huybrechts, BT Bateman, K Palmsten, RJ Desai, E Patorno, ...
Jama 313 (21), 2142-2151, 2015
2912015
Using real-world data to predict findings of an ongoing phase IV cardiovascular outcome trial: cardiovascular safety of linagliptin versus glimepiride
E Patorno, S Schneeweiss, C Gopalakrishnan, D Martin, JM Franklin
Diabetes care 42 (12), 2204-2210, 2019
1032019
Effect of a remotely delivered tailored multicomponent approach to enhance medication taking for patients with hyperlipidemia, hypertension, and diabetes: the STIC2IT cluster …
NK Choudhry, T Isaac, JC Lauffenburger, C Gopalakrishnan, M Lee, ...
JAMA internal medicine 178 (9), 1182-1189, 2018
892018
Claims‐based studies of oral glucose‐lowering medications can achieve balance in critical clinical variables only observed in electronic health records
E Patorno, C Gopalakrishnan, JM Franklin, KG Brodovicz, ...
Diabetes, Obesity and Metabolism 20 (4), 974-984, 2018
752018
Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection
C Gopalakrishnan, K Bykov, MA Fischer, JG Connolly, JJ Gagne, ...
JAMA internal medicine 180 (12), 1596-1605, 2020
562020
Brief report: patterns and secular trends in use of immunomodulatory agents during pregnancy in women with rheumatic conditions
RJ Desai, KF Huybrechts, BT Bateman, S Hernandez‐Diaz, H Mogun, ...
Arthritis & Rheumatology 68 (5), 1183-1189, 2016
472016
Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK
L Li, S Jick, C Gopalakrishnan, U Heide‐Jørgensen, H Nørrelund, ...
Diabetic Medicine 34 (4), 485-489, 2017
312017
Comparative cardiovascular safety of glucagon‐like peptide‐1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study
E Patorno, BM Everett, AB Goldfine, RJ Glynn, J Liu, C Gopalakrishnan, ...
Diabetes, Obesity and Metabolism 18 (8), 755-765, 2016
312016
Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial
NK Choudhry, T Isaac, JC Lauffenburger, C Gopalakrishnan, NF Khan, ...
American heart journal 180, 90-97, 2016
302016
The relative benefits of claims and electronic health record data for predicting medication adherence trajectory
JM Franklin, C Gopalakrishnan, AA Krumme, K Singh, JR Rogers, ...
American heart journal 197, 153-162, 2018
292018
Comparative risk of harm associated with the use of targeted immunomodulators: a systematic review
RJ Desai, KJ Thaler, P Mahlknecht, G Gartlehner, MS McDonagh, ...
Arthritis Care & Research 68 (8), 1078-1088, 2016
282016
Prevalence and impact of having multiple barriers to medication adherence in nonadherent patients with poorly controlled cardiometabolic disease
JC Lauffenburger, T Isaac, R Bhattacharya, TD Sequist, ...
The American journal of cardiology 125 (3), 376-382, 2020
242020
Association of type of oral anticoagulant dispensed with adverse clinical outcomes in patients extending anticoagulation therapy beyond 90 days after hospitalization for venous …
A Pawar, JJ Gagne, C Gopalakrishnan, G Iyer, H Tesfaye, G Brill, K Chin, ...
Jama 327 (11), 1051-1060, 2022
182022
Safety and effectiveness of dabigatran and other direct oral anticoagulants compared with warfarin in patients with atrial fibrillation
KF Huybrechts, C Gopalakrishnan, DB Bartels, K Zint, VK Gurusamy, ...
Clinical Pharmacology & Therapeutics 107 (6), 1405-1419, 2020
152020
Evaluation of socioeconomic status indicators for confounding adjustment in observational studies of medication use
C Gopalakrishnan, JJ Gagne, A Sarpatwari, SZ Dejene, SK Dutcher, ...
Clinical Pharmacology & Therapeutics 105 (6), 1513-1521, 2019
152019
Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease
JC Lauffenburger, CP Fontanet, T Isaac, C Gopalakrishnan, TD Sequist, ...
American heart journal 228, 36-43, 2020
142020
Claims data studies of direct oral anticoagulants can achieve balance in important clinical parameters only observable in electronic health records
KF Huybrechts, C Gopalakrishnan, JM Franklin, K Zint, LR Franca, ...
Clinical Pharmacology & Therapeutics 105 (4), 979-993, 2019
142019
Evaluating utilization patterns of oral anticoagulants in routine care
C Gopalakrishnan, S Schneeweiss, DB Bartels, K Zint, A Santiago Ortiz, ...
Journal of Thrombosis and Haemostasis, 2019
122019
Sequential monitoring of the comparative effectiveness and safety of dabigatran in routine care
S Schneeweiss, C Gopalakrishnan, DB Bartels, JM Franklin, K Zint, ...
Circulation: Cardiovascular Quality and Outcomes 12 (2), e005173, 2019
112019
Empagliflozin and the risk of heart failure hospitalization in routine clinical care: a first analysis from the empagliflozin comparative effectiveness and safety (EMPRISE) study
E Patorno, A Pawar, J Franklin, M Najafzadeh, A Déruaz-Luyet, ...
Proceedings of the American Heart Association Scientific Sessions, 10-12, 2018
92018
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20